Tokyo, Japan and London, UK, 4 June 2018 – Sosei Group Corporation (“Sosei” or the “Company”; TSE Mothers Index: 4565), the world leader in GPCR medicine design and development, today announces the resignation of an Executive Officer. The details are as follows.

 

    Mr. Andrew Oakley, Executive Officer, Executive Vice President and CFO

2. Effective Date of Resignation

    4 June 2018

3. Reason for Resignation

    For personal reasons

4. Other Information

    The Board of Directors, at its meeting held on 4 June 2018, appointed Mr. Chris Cargill, currently Senior Vice President of Corporate Strategy and Head of Investor Relations and 

    Corporate Communications, as the Company’s interim CFO.

    Mr. Cargill joined Sosei in September 2017 and has more than a decade of experience in corporate finance divisions at major companies around the world.

    The Company will make an announcement regarding a new CFO as soon as the appointment is made.